Le SIDA en Afrique subsaharienne (serveur d'exploration) - Analysis (RSA)

Index « Auteurs » - entrée « Graeme Meintjes »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Graeme A. Meintjes < Graeme Meintjes < Graham D. Ogle  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000090 (2017) Liam Bell [Afrique du Sud] ; Janique M. Peyper [Afrique du Sud] ; Shaun Garnett [Afrique du Sud] ; Rabecca Tadokera [Afrique du Sud] ; Robert Wilkinson [Royaume-Uni] ; Graeme Meintjes [Afrique du Sud] ; Jonathan M. Blackburn [Afrique du Sud]TB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasone.
000439 (2017) Erin Stern [Afrique du Sud] ; Christopher Colvin [Afrique du Sud] ; Nobom Gxabagxaba [Afrique du Sud] ; Charlotte Schutz [Afrique du Sud] ; Rosie Burton [Afrique du Sud] ; Graeme Meintjes [Afrique du Sud]Conceptions of agency and constraint for HIV-positive patients and healthcare workers to support long-term engagement with antiretroviral therapy care in Khayelitsha, South Africa.
000476 (2017) Tom H. Boyles [Afrique du Sud] ; Elizabeth Gatley ; Sean Wasserman ; Graeme MeintjesBrief Report: Flow Rate of Cerebrospinal Fluid Through a Spinal Needle Can Accurately Predict Intracranial Pressure in Cryptococcal Meningitis.
000520 (2017) Darius Armstrong-James [Royaume-Uni] ; Tihana Bicanic [Royaume-Uni] ; Gordon D. Brown [Royaume-Uni] ; Jennifer C. Hoving [Afrique du Sud] ; Graeme Meintjes [Afrique du Sud] ; Kirsten Nielsen [États-Unis]AIDS-Related Mycoses: Current Progress in the Field and Future Priorities.
000532 (2017) Johanna Rhodes ; Mathew A. Beale [Royaume-Uni] ; Mathieu Vanhove ; Joseph N. Jarvis [Botswana] ; Shichina Kannambath ; John A. Simpson [Afrique du Sud] ; Anthea Ryan [Afrique du Sud] ; Graeme Meintjes [Afrique du Sud] ; Thomas S. Harrison ; Matthew C. Fisher [Royaume-Uni] ; Tihana Bicanic [Royaume-Uni]A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection.
000570 (2016) Janneke A. Cox [Belgique] ; Daniel Kiggundu [Ouganda] ; Lana Elpert [États-Unis] ; Graeme Meintjes [Afrique du Sud] ; Robert Colebunders [Belgique] ; Stella Alamo [Ouganda]Temporal trends in death causes in adults attending an urban HIV clinic in Uganda: a retrospective chart review
000653 (2015) Graeme Meintjes [Afrique du Sud, Royaume-Uni] ; Liezl Dunn [Afrique du Sud] ; Marla Coetsee [Afrique du Sud] ; Michael Hislop [Afrique du Sud] ; Rory Leisegang [Afrique du Sud] ; Leon Regensberg [Afrique du Sud] ; Gary Maartens [Afrique du Sud]Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study
000A73 (2013) Naomi F. Walker [Royaume-Uni, Afrique du Sud] ; Graeme Meintjes [Afrique du Sud, Royaume-Uni] ; Robert J. Wilkinson [Afrique du Sud, Royaume-Uni]HIV-1 and the immune response to TB
000B20 (2013) Helen Van Der Plas [Afrique du Sud] ; Graeme Meintjes ; Charlotte Schutz ; Rene Goliath ; Landon Myer ; Dorothea Baatjie ; Robert J. Wilkinson ; Gary Maartens ; Marc MendelsonComplications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis.
000B65 (2013) Chris Kenyon [Afrique du Sud] ; Kim Bonorchis ; Craig Corcoran ; Graeme Meintjes ; Michael Locketz ; Rannakoe Lehloenya ; Hester F. Vismer ; Preneshni Naicker ; Hans Prozesky ; Marelize Van Wyk ; Colleen Bamford ; Moira Du Plooy ; Gail Imrie ; Sipho Dlamini ; Andrew M. Borman ; Robert Colebunders ; Cedric P. Yansouni ; Marc Mendelson ; Nelesh P. GovenderA dimorphic fungus causing disseminated infection in South Africa.
000D42 (2012) Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Anthony D. Harries [Royaume-Uni, France] ; Graeme Meintjes [Afrique du Sud, Royaume-Uni] ; Haileyesus Getahun [Suisse] ; Diane V. Havlir [États-Unis] ; Robin Wood [Afrique du Sud]Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa
000F81 (2010) Karen Cohen [Afrique du Sud] ; Graeme MeintjesManagement of individuals requiring antiretroviral therapy and TB treatment.
001003 (2010) Angela Loyse [Afrique du Sud] ; Helen Wainwright ; Joseph N. Jarvis ; Tihana Bicanic ; Kevin Rebe ; Graeme Meintjes ; Thomas S. HarrisonHistopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure.
001066 (2010) Dominique J. Pepper [Afrique du Sud] ; Suzaan Marais ; Robert J. Wilkinson ; Feriyl Bhaijee ; Gary Maartens ; Helen Mcilleron ; Virginia De Azevedo ; Helen Cox ; Cheryl Mcdermid ; Simiso Sokhela ; Janisha Patel ; Graeme MeintjesClinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.
001078 (2010) Valerie Asselman [Afrique du Sud] ; Friedrich Thienemann ; Dominique J. Pepper ; Andrew Boulle ; Robert J. Wilkinson ; Graeme Meintjes ; Suzaan MaraisCentral nervous system disorders after starting antiretroviral therapy in South Africa.
001120 (2010) Graeme Meintjes [Afrique du Sud, Royaume-Uni] ; Robert J. Wilkinson [Afrique du Sud, Royaume-Uni]Undiagnosed Active Tuberculosis in HIV-Infected Patients Commencing Antiretroviral Therapy
001131 (2010) Graeme Meintjes [Afrique du Sud, Royaume-Uni] ; Robert J. Wilkinson [Afrique du Sud, Royaume-Uni]Optimum Timing of Antiretroviral Therapy for HIV-Infected Patients with Concurrent Serious Opportunistic Infections
001266 (2009) Mary-Ann Davies [Afrique du Sud] ; Graeme Meintjes [Afrique du Sud]Assessing the Contribution of the Immune Reconstitution Inflammatory Syndrome to Mortality in Developing Country Antiretroviral Therapy Programs

List of associated KwdEn.i

Nombre de
documents
Descripteur
9Humans
7Female
7Male
6Adult
4Prospective Studies
3AIDS-Related Opportunistic Infections (microbiology)
3Anti-HIV Agents (therapeutic use)
3Antiretroviral Therapy, Highly Active
3CD4 Lymphocyte Count
3HIV Infections (complications)
3HIV Infections (drug therapy)
3South Africa
3Tuberculosis (drug therapy)
2AIDS-Related Opportunistic Infections (drug therapy)
2AIDS-Related Opportunistic Infections (pathology)
2Anti-HIV Agents (adverse effects)
2Antitubercular Agents (therapeutic use)
2Cohort Studies
2HIV Infections (pathology)
2HIV Infections (virology)
2Meningitis, Cryptococcal (pathology)
2Risk Factors
2South Africa (epidemiology)
2Tuberculosis (complications)
1AIDS
1AIDS-Related Opportunistic Infections (cerebrospinal fluid)
1AIDS-Related Opportunistic Infections (chemically induced)
1AIDS-Related Opportunistic Infections (epidemiology)
1AIDS-Related Opportunistic Infections (physiopathology)
1Adolescent
1Africa
1Aged
1Anti-HIV Agents (administration & dosage)
1Anti-Retroviral Agents (therapeutic use)
1Antiretroviral agent
1Antitubercular Agents (administration & dosage)
1Antitubercular Agents (adverse effects)
1Antiviral
1Arachnoid (pathology)
1Benzoxazines (adverse effects)
1Cerebrospinal Fluid (chemistry)
1Cerebrospinal Fluid Pressure (physiology)
1Chemical Phenomena
1Chromatography, Liquid
1Chrysosporium (classification)
1Chrysosporium (genetics)
1Chrysosporium (isolation & purification)
1Chrysosporium (pathogenicity)
1Coinfection (drug therapy)
1Comorbidity
1Dexamethasone (therapeutic use)
1Diagnosis
1Drug Interactions
1Gene Expression Regulation
1HIV Infections (cerebrospinal fluid)
1HIV Infections (diagnosis)
1HIV Infections (epidemiology)
1HIV Infections (immunology)
1HIV Infections (microbiology)
1HIV Infections (mortality)
1HIV Seropositivity (drug therapy)
1HIV Seropositivity (epidemiology)
1HIV Seropositivity (physiopathology)
1HIV-1 (drug effects)
1HIV-1 (isolation & purification)
1Health Personnel (psychology)
1Human immunodeficiency virus
1Immune Reconstitution Inflammatory Syndrome
1Immune Reconstitution Inflammatory Syndrome (chemically induced)
1Immune Reconstitution Inflammatory Syndrome (drug therapy)
1Immune Reconstitution Inflammatory Syndrome (epidemiology)
1Immune Reconstitution Inflammatory Syndrome (physiopathology)
1Incidence
1Intracranial Hypertension (cerebrospinal fluid)
1Intracranial Hypertension (diagnosis)
1Intracranial Hypertension (microbiology)
1Intracranial Hypertension (pathology)
1Leukocytes, Mononuclear (drug effects)
1Leukocytes, Mononuclear (microbiology)
1Medication Adherence (psychology)
1Meningitis, Cryptococcal (cerebrospinal fluid)
1Meningitis, Cryptococcal (microbiology)
1Middle Aged
1Mortality
1Mycobacterium tuberculosis
1Mycobacterium tuberculosis (drug effects)
1Mycoses (microbiology)
1Phylogeny
1Professional-Patient Relations
1Prognosis
1Proteome (metabolism)
1Proteomics
1Public Health Surveillance
1Qualitative Research
1Randomized Controlled Trials as Topic
1Reverse Transcriptase Inhibitors (administration & dosage)
1Reverse Transcriptase Inhibitors (adverse effects)
1Reverse Transcriptase Inhibitors (therapeutic use)
1Socioeconomic Factors
1Spinal Puncture (methods)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/RSA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i -k "Graeme Meintjes" 
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i  \
                -Sk "Graeme Meintjes" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/RSA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    RSA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Graeme Meintjes
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024